The Value of an Onglyza Lawsuit Loan
The recent news about the dangers of diabetes drug Onglyza is expected to result in an onslaught of product liability lawsuits brought by those who suffered serious injury or the loss of the loved one due to alleged side effects of the medication. While the legal system affords victims the ability to seek financial compensation and accountability for harm done by unsafe medications, the path to justice through the courts can be slow. When it comes to staying afloat financially in the meantime, drug injury lawsuit funding from legal loan industry leader LawStreet Capital can prove critical.
Medical treatment costs, rehabilitation expenses, inability to work, reduced earning capacity and sometimes even funeral bills can put an enormous financial burden on defective drug victims and their families. As a result, far too many victims end up settling their legal matters for far less than they justly deserve, just to get some much-needed resources sooner.
The good news is that Onglyza lawsuit funding from LawStreet Capital can prevent victims from ever having to make this type of decision.
How drug injury lawsuit funding can make a difference
Onglyza lawsuit loans available from LawStreet Capital can help you secure the resources necessary to pay everyday expenses and meet other obligations while you wait for your case to be resolved, whether through a negotiated settlement or at trial. This type of financial advance is based entirely on your expected settlement or award and is rightly described as non-recourse. No payments will ever come due on the amount advanced unless and until your prevail in your legal case.
If things turn out differently than you anticipated, and you do not win any type of settlement or jury award, you will not have any duty to repay LawStreet Capital.
A LawStreet Capital lawsuit loan is hassle-free and convenient. After you complete a free, no-obligation loan application, a member of our team will connect with your lawyer to learn the facts of your legal case. We strive to make rapid funding decisions, usually within 24 hours of application. You have the freedom to choose the amount we send you, up to your loan limit, via conventional check or electronic transfer.
Onglyza lawsuits expected to grow
In recent months, alarm bells have been sounding nationwide about the potential dangers posed by popular diabetes drug Onglyza, manufactured by pharmaceutical giant AstraZeneca. Most concerning are the possible links between use of the medication and the development of life-threatening conditions such as heart failure and pancreatic cancer.
A study published in the journal Gastroenterology in 2011 revealed that those using incretin mimetic drugs such as Onglyza developed pancreatic cancer at a rate of 2.7 percent higher than other diabetic patients.
In April, 2015, the U.S. Food and Drug Administration reported that Onglyza use raises the risk of death from any and all causes, including heart complications. The FDA has recommended that the drug’s labeling be changed to strengthen patient awareness of potential heart failure risks.
Learn more by contacting LawStreet Capital
Even under the best of scenarios, pursuing compensation through the legal system is generally a lengthy, complicated process, and personal finances can take a serious hit in the meantime. For these reasons, it is wise to consider the option of Onglyza legal funding from LawStreet Capital.
We are proud to offer plaintiffs the funds necessary to cover medical bills, mortgage payments and other essential expenses that are simply part of daily life. Since there is no obligation to repay the funds if the lawsuit is unsuccessful, there is no risk at all to you.
Our online application process is quick and uncomplicated, and we attempt to provide you with a decision in just 24 hours. Contact LawStreet Capital today at 888-562-0363, and get the peace of mind you deserve.
